Clonal selection drives genetic divergence of metastatic medulloblastoma

Xiaochong Wu, Paul A. Northcott, Adrian Dubuc, Adam J. Dupuy, David J H Shih, Hendrik Witt, Sidney Croul, Eric Bouffet, Daniel W. Fults, Charles G. Eberhart, Livia Garzia, Timothy Van Meter, David Zagzag, Nada Jabado, Jeremy Schwartzentruber, Jacek Majewski, Todd E. Scheetz, Stefan M. Pfister, Andrey Korshunov, Xiao Nan LiStephen W. Scherer, Yoon Jae Cho, Keiko Akagi, Tobey J. MacDonald, Jan Koster, Martin G. McCabe, Aaron L. Sarver, V. Peter Collins, William A. Weiss, David A. Largaespada, Lara S. Collier, Michael D. Taylor

Research output: Contribution to journalArticlepeer-review

325 Scopus citations


Medulloblastoma, the most common malignant paediatric brain tumour, arises in the cerebellum and disseminates through the cerebrospinal fluid in the leptomeningeal space to coat the brain and spinal cord. Dissemination, a marker of poor prognosis, is found in up to 40% of children at diagnosis and in most children at the time of recurrence. Affected children therefore are treated with radiation to the entire developing brain and spinal cord, followed by high-dose chemotherapy, with the ensuing deleterious effects on the developing nervous system. The mechanisms of dissemination through the cerebrospinal fluid are poorly studied, and medulloblastoma metastases have been assumed to be biologically similar to the primary tumour. Here we show that in both mouse and human medulloblastoma, the metastases from an individual are extremely similar to each other but are divergent from the matched primary tumour. Clonal genetic events in the metastases can be demonstrated in a restricted subclone of the primary tumour, suggesting that only rare cells within the primary tumour have the ability to metastasize. Failure to account for the bicompartmental nature of metastatic medulloblastoma could be a major barrier to the development of effective targeted therapies.

Original languageEnglish (US)
Pages (from-to)529-533
Number of pages5
Issue number7386
StatePublished - Feb 23 2012

Bibliographical note

Funding Information:
Acknowledgements M.D.T. holds a Canadian Institutes of Health Research Clinician-Scientist PhaseIIAward,was aSontagFoundationDistinguishedScholar,and is supported by grants from the National Institutes of Health (R01CA148699), the Pediatric Brain Tumor Foundation, the Canadian Cancer Society, and Brainchild. X.W. was supported by a fellowship from the American Brain Tumor Association in tribute to Tracy Greenwood. L.G. was supported by a fellowship from the Davis M. Ferguson Fund from the American Brain Tumor Association. A.D. was supported by a Vanier Doctoral Fellowship from the Canadian Institutes of Health Research. L.S.C. was supported by a grant (K01CA122183) and a Kimmel Scholar award from the Kimmel Foundation. C.E. was supported by a grant from the National Institutes of Health (NS055089). We thank S. Archer for technical writing assistance.


Dive into the research topics of 'Clonal selection drives genetic divergence of metastatic medulloblastoma'. Together they form a unique fingerprint.

Cite this